We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$31.9B
AUM Growth
+$2.38B
Cap. Flow
+$1.7B
Cap. Flow %
5.32%
Top 10 Hldgs %
15.42%
Holding
3,195
New
265
Increased
1,619
Reduced
1,032
Closed
182

Sector Composition

Rank Sector Weight
1 Healthcare 9.59%
2 Technology 8.36%
3 Consumer Staples 8.04%
4 Financials 7.78%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSKX
2976
DELISTED
DS HEALTHCARE GROUP, INC. NEW COMMON STOCK
DSKX
$6K ﹤0.01%
47,976
CCL icon
2977
CALL
Carnival Corporation Ltd
CCL
$39.7B
$5K ﹤0.01%
50,800
+4,300
+9% +$211K
DD icon
2978
CALL
DuPont de Nemours
DD
$19.2B
$5K ﹤0.01%
6,989
+1,816
+35% +$239K
MCD icon
2979
CALL
McDonald's
MCD
$195B
$5K ﹤0.01%
12,000
+700
+6% +$87.7K
OVV icon
2980
CALL
Ovintiv
OVV
$16.4B
$5K ﹤0.01%
+3,080
New +$113K
XLE icon
2981
CALL
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$5K ﹤0.01%
+22,000
New +$726K
RXII
2982
DELISTED
GALENA BIOPHARMA INC COM
RXII
$5K ﹤0.01%
10,500
-3,585
-25% -$1.71K
V icon
2983
CALL
Visa
V
$677B
$4K ﹤0.01%
+23,300
New +$1.82M
EFA icon
2984
CALL
iShares MSCI EAFE ETF
EFA
$80.2B
$3K ﹤0.01%
14,100
+4,000
+40% +$230K
HD icon
2985
CALL
Home Depot
HD
$355B
$3K ﹤0.01%
18,400
-25,400
-58% -$3.36M
OMER icon
2986
CALL
Omeros
OMER
$959M
$3K ﹤0.01%
10,100
-55,800
-85% -$687K
TT icon
2987
CALL
Trane Technologies
TT
$106B
$3K ﹤0.01%
+13,600
New +$875K
ESRX
2988
CALL
DELISTED
Express Scripts Holding Company
ESRX
$3K ﹤0.01%
+10,700
New +$787K
IMUC
2989
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$3K ﹤0.01%
380
-8
-2% -$82
GCVRZ
2990
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3K ﹤0.01%
11,384
COP icon
2991
CALL
ConocoPhillips
COP
$141B
$2K ﹤0.01%
+12,900
New +$569K
EMR icon
2992
CALL
Emerson Electric
EMR
$88.3B
$2K ﹤0.01%
18,300
+600
+3% +$31.9K
HSBC icon
2993
CALL
HSBC
HSBC
$356B
$2K ﹤0.01%
+17,621
New +$498K
IBM icon
2994
CALL
IBM
IBM
$224B
$2K ﹤0.01%
23,221
+9,728
+72% +$1.39M
YELL
2995
CALL
DELISTED
Yellow Corporation Common Stock
YELL
$2K ﹤0.01%
17,000
AA icon
2996
CALL
Alcoa
AA
$13.2B
$1K ﹤0.01%
6,284
CYHHZ
2997
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
35,880
-225
-0.6% -$1
BAC.WS.B
2998
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$1K ﹤0.01%
12,300
KMI.WS
2999
DELISTED
Kinder Morgan Inc
KMI.WS
$1K ﹤0.01%
23,149
-22,637
-49% -$632
ACN icon
3000
CALL
Accenture
ACN
$108B
-18,300
Closed -$48K

Similar funds

Raymond James & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Raymond James & Associates held 3,195 positions worth $31.9B, up 8.1% from $29.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $1.7B of net new capital in Q2 2016, opening 265 new positions and adding to 1,619 existing holdings. Its largest new stake was Schwab US REIT ETF: 467,710 shares worth $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.6% of assets, up from 9% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was WisdomTree Europe Hedged Equity Fund, an estimated $43.1M trimmed.

  • Raymond James & Associates's largest Q2 2016 buy was Schwab US REIT ETF: 467,710 shares worth $10.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2016, an estimated $107M increase.
  • Raymond James & Associates's biggest Q2 2016 reduction was WisdomTree Europe Hedged Equity Fund, cutting an estimated $43.1M.
  • Raymond James & Associates fully exited ADT Corp in Q2 2016, selling an estimated $34.4M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $31.9B portfolio in Q2 2016.
  • Raymond James & Associates opened 265 new positions and closed 182 in Q2 2016.
  • Raymond James & Associates's portfolio value rose 8.1% quarter-over-quarter to $31.9B.

Based on Raymond James & Associates's 13F filing for Q2 2016, filed 11 Aug 2016.